Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:CNC
CUSIP15135B10
Phone314-725-4477
Debt
Debt-to-Equity Ratio0.59
Current Ratio1.25
Quick Ratio1.26
Price-To-Earnings
Trailing P/E Ratio28.00
Forward P/E Ratio19.69
P/E Growth1.4
Sales & Book Value
Annual Sales$48.38 billion
Price / Sales0.59
Cash Flow$6.9745 per share
Price / Cash19.99
Book Value$39.78 per share
Price / Book3.50
Profitability
EPS (Most Recent Fiscal Year)$5.03
Net Income$828 million
Net Margins2.06%
Return on Equity14.57%
Return on Assets4.74%
Miscellaneous
Employees33,700
Outstanding Shares205,260,000
Market Cap$29.72 billion
Centene (NYSE:CNC) Frequently Asked Questions
What is Centene's stock symbol?
Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
How were Centene's earnings last quarter?
Centene Corp (NYSE:CNC) issued its earnings results on Tuesday, July, 24th. The company reported $1.80 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.77 by $0.03. The company earned $14.18 billion during the quarter, compared to the consensus estimate of $13.82 billion. Centene had a return on equity of 14.57% and a net margin of 2.06%. The firm's revenue for the quarter was up 18.6% compared to the same quarter last year. During the same period last year, the business posted $1.59 EPS. View Centene's Earnings History.
When is Centene's next earnings date?
How can I listen to Centene's earnings call?
Centene will be holding an earnings conference call on Tuesday, October 23rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8778830383.
What guidance has Centene issued on next quarter's earnings?
Centene updated its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share (EPS) guidance of $6.80-7.16 for the period, compared to the Thomson Reuters consensus estimate of $7.05. The company issued revenue guidance of $59.2-60 billion, compared to the consensus revenue estimate of $59.30 billion.
What price target have analysts set for CNC?
16 brokers have issued 1 year target prices for Centene's stock. Their forecasts range from $115.00 to $175.00. On average, they anticipate Centene's stock price to reach $147.50 in the next twelve months. This suggests a possible upside of 5.8% from the stock's current price. View Analyst Price Targets for Centene.
What is the consensus analysts' recommendation for Centene?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.
What are Wall Street analysts saying about Centene stock?
Here are some recent quotes from research analysts about Centene stock:
- 1. According to Zacks Investment Research, "Centene’s shares have outperformed its industry’s gain in the past year. The company has been performing really well on the back of higher revenues, primarily driven by growth in the Health Insurance Marketplace business in 2018, strategic acquisitions, expansions and new programs across many of the states in 2017 and 2018 as well as the reinstatement of the health insurer fee in 2018. Its raised 2018 guidance should instill investors’ confidence in the stock. However, it is burdened with high debts. The long-term debt has been rising since 2005, mainly because the company’s acquisitions are financed majorly by borrowings. Apart from long term debt, increasing interest expenses weighs on its margins. Escalating operating costs since 2007 remains another concern." (10/4/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Centene filed an 8-K which indicates that it will contribute $340 million (over five years) to New York State in conjunction with the Fidelis acquisition." (4/2/2018)
Who are some of Centene's key competitors?
Who are Centene's key executives?
Centene's management team includes the folowing people:
- Mr. Michael Frederic Neidorff, Chairman & CEO (Age 75)
- Ms. Cynthia J. Brinkley, Pres , COO, Chief Admin. & Markets Officer (Age 58)
- Mr. Jeffrey Alan Schwaneke CPA, CPA, Exec., CFO & Treasurer (Age 42)
- Mr. Keith Harvey Williamson, Exec. VP, Gen. Counsel & Corp. Sec. (Age 66)
- Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 42)
Who are Centene's major shareholders?
Centene's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bank of Montreal Can (0.28%), Barometer Capital Management Inc. (0.05%), Hennessy Advisors Inc. (0.03%), State of Alaska Department of Revenue (0.02%), Rhenman & Partners Asset Management AB (0.02%) and Douglass Winthrop Advisors LLC (0.02%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.
Which institutional investors are selling Centene stock?
CNC stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Rhenman & Partners Asset Management AB, Hennessy Advisors Inc., Oliver Luxxe Assets LLC, Murphy Capital Management Inc., CENTRAL TRUST Co, Douglass Winthrop Advisors LLC and Parkside Financial Bank & Trust. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Christopher D Bowers, Jesse N Hunter, Keith H Williamson, Michael F Neidorff and Robert K Ditmore. View Insider Buying and Selling for Centene.
Which institutional investors are buying Centene stock?
CNC stock was bought by a variety of institutional investors in the last quarter, including Barometer Capital Management Inc., Polianta Ltd, Iberiabank Corp, Lourd Capital LLC, DNB Asset Management AS, Private Trust Co. NA, We Are One Seven LLC and Atria Investments LLC. View Insider Buying and Selling for Centene.
How do I buy shares of Centene?
Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene's stock price today?
One share of CNC stock can currently be purchased for approximately $139.42.
How big of a company is Centene?
Centene has a market capitalization of $29.72 billion and generates $48.38 billion in revenue each year. The company earns $828 million in net income (profit) each year or $5.03 on an earnings per share basis. Centene employs 33,700 workers across the globe.
What is Centene's official website?
How can I contact Centene?
Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]
MarketBeat Community Rating for Centene (NYSE CNC)
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
